Lasry Marc
Avenue Capital Group, founded in 1995 by Marc Lasry and Sonia Gardner, is a global alternative investment manager headquartered in New York. The firm is recognized as one of the largest investors in distressed and undervalued debt and equity opportunities globally. Serving institutional investors and high-net-worth clients, Avenue manages approximately $12.3 billion in assets and employs over 175 professionals across offices in the US, Europe, Asia, Silicon Valley, and Abu Dhabi. The firm is a leader in specialty lending and opportunistic credit.
Investment Strategy
Avenue Capital Group focuses on specialty lending, opportunistic credit, and other special situations investments across the United States, Europe, and Asia. The firm pursues value creation and capital conservation by proactively identifying distressed or fragmented markets, conducting rigorous due diligence, and extracting premium through investments in undervalued debt and equity. The team deploys capital in public and private opportunities, emphasizing sectors and regions where its expertise in distressed investing can generate superior risk-adjusted returns.
Latest 13F Filing Activity
Lasry Marc filed their most recent 13F report on Jun 30, 2025 disclosing 7 equity positions with a total 13F market value of $18M. The fund increased holdings in Nextdecade Corp., Forge Global Holdings Inc., Dariohealth Corp. among other positions. Lasry Marc reduced exposure to Alexanders Inc., Beyond Air Inc., Orchestra Biomed HLDGS Inc. among others.
Top Holdings
Equity Positions (7)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
N NEXT | NEXTDECADE CORP | 12.67% | $2.3M | 254,270 | $5.23 | $8.91 | +$287.3K |
D DRIO | DARIOHEALTH CORP | 1.74% | $311.5K | 464,908 | $0.79 | $0.67 | +$26.9K |
X XAIR | BEYOND AIR INC | 1.58% | $282.4K | 1,639,022 | $0.39 | $3.45 | -$164.2K |
F FRGE | FORGE GLOBAL HOLDINGS INC | 1.21% | $216.4K | 11,363 | $19.04 | $19.04 | +$216.4K |
O OBIO | ORCHESTRA BIOMED HLDGS INC | 0.91% | $163.1K | 60,869 | $7.00 | $2.68 | -$97.4K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more